Provided by Tiger Fintech (Singapore) Pte. Ltd.

GeneDx Holdings

98.47
+9.1510.24%
Post-market: 98.40-0.0700-0.07%19:18 EDT
Volume:915.50K
Turnover:90.20M
Market Cap:2.76B
PE:-50.64
High:101.35
Open:91.19
Low:90.20
Close:89.32
Loading ...

Stock Track | GeneDx Soars on Surging Exome and Genome Testing Growth

Stock Track
·
30 Oct 2024

GeneDx Holdings Is Maintained at Buy by Craig-Hallum

Dow Jones
·
30 Oct 2024

GeneDx price target raised to $95 from $70 at Craig-Hallum

TIPRANKS
·
30 Oct 2024

GeneDx Holdings Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
30 Oct 2024

GeneDx Holdings Corp. : Craig-Hallum Raises Target Price to $95 From $70

THOMSON REUTERS
·
30 Oct 2024

GeneDx Holdings Corp (WGS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and First ...

GuruFocus.com
·
30 Oct 2024

Q3 2024 GeneDx Holdings Corp Earnings Call

Thomson Reuters StreetEvents
·
30 Oct 2024

GeneDx Holdings: Impressive Growth Undermined by High Valuation Leading to Hold Rating

TIPRANKS
·
30 Oct 2024

Stock Track | GeneDx Stock Soars on Q3 Beat and Raised Guidance Amid Robust Genomic Testing Growth

Stock Track
·
30 Oct 2024

Strong Financial Performance and Growth Potential Justify Buy Rating for GeneDx Holdings

TIPRANKS
·
30 Oct 2024

GeneDx price target raised to $95 from $45 at BTIG

TIPRANKS
·
30 Oct 2024

GeneDx Shares Skyrocket 50% Today on Profit Milestone and Surge in Genomic Growth

GuruFocus.com
·
30 Oct 2024

GeneDx climbs after profitability milestone in Q3

seekingalpha
·
29 Oct 2024

Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance

Benzinga
·
29 Oct 2024

GeneDx Shares Hit 52-Week High on 3Q Rev, Raised 2024 Guidance

Dow Jones
·
29 Oct 2024

GeneDx Holdings Corp reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
29 Oct 2024